Is CDK9 a promising target for both primary and metastatic osteosarcoma?

por Qin, Jiang-Jiang
Publicado 2019

Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies

por Wu, Xiaofan, Yang, Hongjian, Yu, Xingfei, Qin, Jiang-Jiang
Publicado 2022

STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review

por Qin, Jiang-Jiang, Yan, Li, Zhang, Jia, Zhang, Wei-Dong
Publicado 2019

Targeting the NFAT1-MDM2-MDMX Network Inhibits the Proliferation and Invasion of Prostate Cancer Cells, Independent of p53 and Androgen

por Qin, Jiang-Jiang, Li, Xin, Wang, Wei, Zi, Xiaolin, Zhang, Ruiwen
Publicado 2017

Dual roles and therapeutic potential of Keap1-Nrf2 pathway in pancreatic cancer: a systematic review

por Qin, Jiang-Jiang, Cheng, Xiang-Dong, Zhang, Jia, Zhang, Wei-Dong
Publicado 2019

Editorial: Biology and Pharmacological Effects of Extracellular Vesicles in Cancer

por Zhang, Jian-ye, Qin, Jiang-Jiang, Zhang, Dongmei, Yang, Dong-Hua
Publicado 2022

Identification of lineariifolianoid A as a novel dual NFAT1 and MDM2 inhibitor for human cancer therapy

por Qin, Jiang-Jiang, Sarkar, Sushanta, Voruganti, Sukesh, Agarwal, Rajesh, Wang, Wei, Zhang, Ruiwen
Publicado 2016

Inulanolide A as a new dual inhibitor of NFAT1-MDM2 pathway for breast cancer therapy

por Qin, Jiang-Jiang, Wang, Wei, Sarkar, Sushanta, Voruganti, Sukesh, Agarwal, Rajesh, Zhang, Ruiwen
Publicado 2016

Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicine

por Qin, Jiang-Jiang, Li, Xin, Hunt, Courtney, Wang, Wei, Wang, Hui, Zhang, Ruiwen
Publicado 2018

Identification of an Immune Gene-Associated Prognostic Signature and Its Association With a Poor Prognosis in Gastric Cancer Patients

por Guan, Xiaoqing, Xu, Zhi-Yuan, Chen, Runzhe, Qin, Jiang-Jiang, Cheng, Xiang-Dong
Publicado 2021

In Silico Screening and Validation of PDGFRA Inhibitors Enhancing Radioiodine Sensitivity in Thyroid Cancer

por Yu, Xuefei, Zhu, Xuhang, Zhang, Lizhuo, Qin, Jiang-Jiang, Feng, Chunlai, Li, Qinglin
Publicado 2022

Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation

por Qin, Jiang-Jiang, Wang, Wei, Voruganti, Sukesh, Wang, Hui, Zhang, Wei-Dong, Zhang, Ruiwen
Publicado 2014

Inhibiting NFAT1 for breast cancer therapy: New insights into the mechanism of action of MDM2 inhibitor JapA

por Qin, Jiang-Jiang, Wang, Wei, Voruganti, Sukesh, Wang, Hui, Zhang, Wei-Dong, Zhang, Ruiwen
Publicado 2015

Inhibiting β-Catenin by β-Carboline-Type MDM2 Inhibitor for Pancreatic Cancer Therapy

por Qin, Jiang-Jiang, Wang, Wei, Li, Xin, Deokar, Hemantkumar, Buolamwini, John K., Zhang, Ruiwen
Publicado 2018

Synthesis, Characterization, Cellular Uptake, and In Vitro Anticancer Activity of Fullerenol-Doxorubicin Conjugates

por Xu, Beihua, Yuan, Li, Hu, Ying, Xu, Zhiyuan, Qin, Jiang-Jiang, Cheng, Xiang-Dong
Publicado 2021

Protein degradation technology: a strategic paradigm shift in drug discovery

por Li, Haobin, Dong, Jinyun, Cai, Maohua, Xu, Zhiyuan, Cheng, Xiang-Dong, Qin, Jiang-Jiang
Publicado 2021

Predicting hERG channel blockers with directed message passing neural networks

por Shan, Mengyi, Jiang, Chen, Chen, Jing, Qin, Lu-Ping, Qin, Jiang-Jiang, Cheng, Gang
Publicado 2022

Platycodin-D exerts its anti-cancer effect by promoting c-Myc protein ubiquitination and degradation in gastric cancer

por Xu, Qianqian, Pan, Guangzhao, Wang, Zhonglan, Wang, Lingling, Tang, Yancheng, Dong, Jinyun, Qin, Jiang-Jiang
Publicado 2023

Ginsenosides as Anticancer Agents: In vitro and in vivo Activities, Structure–Activity Relationships, and Molecular Mechanisms of Action

por Nag, Subhasree Ashok, Qin, Jiang-Jiang, Wang, Wei, Wang, Ming-Hai, Wang, Hui, Zhang, Ruiwen
Publicado 2012

Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance

por Yuan, Li, Xu, Zhi-Yuan, Ruan, Shan-Ming, Mo, Shaowei, Qin, Jiang-Jiang, Cheng, Xiang-Dong
Publicado 2020